This is a $14,906.79 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract is a firm fixed price, non-set-aside award with a completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a global pharmaceutical support vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 240 mg/24 ml vials of the drug OPDIVO, with a ceiling value of $124,223.25 and a period of performance through July 7, 2025. The contract is not set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 100 MG/10 ML VIAL 10ML. The firm fixed-price contract has a ceiling value of $9,974.55 and runs through December 12, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo 240 mg/24 ml vials. The contract has a ceiling value of $14,906.79 and a period of performance ending on June 18, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order is for 240mg/24ml vials of the drug OPDIVO, with a potential value of $38,237.00 and a performance period through February 22, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,813.58 firm fixed-price contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product, with a completion date of February 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a ceiling value of $14,906.79 and is a firm fixed-price delivery order, with an ultimate completion date of June 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 240 mg/24 mL vials of the pharmaceutical product OPDIVO. The contract has a potential value of $22,942.20 and a performance period through February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,689.30, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract is a firm fixed-price delivery order, with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $38,237.00 order is for the supply of 240 mg/24 ml vials of the prescription drug OPDIVO. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...